Suppressed apoptotic induction in esophageal squamous cell carcinomas expressing extensive p53 protein

Japanese Journal of Clinical Oncology

Volumn 26, Issue 6, 1996, Pages 398-404

  Hamada, Madoka ^a   Naomoto, Yoshio ^a   Fujiwara, Toshiyoshi ^a   Kamikawa, Yasuaki ^a   Tanaka, Noriaki ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Esophagus; Gene therapy; p53; Squamous cell carcinoma

Indexed keywords

PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; ESOPHAGUS TUMOR; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RADIATION EXPOSURE; RADIOTHERAPY; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030330589     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jjco.a023255     Document Type: Article

References (30)

1. Japanese Cancer Association: Cancer treatment and survival. Monograph of Cancer Research 43: 39-46, 1995
2. Dive C, Hickman JA: Drug-target interactions: only the first step in the committment to a programmed cell death? Br J Cancer 64: 192-196, 1991
3. Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon wit wide-ranging implications in tissue kinetics Br J Cancer 26: 239-257, 1972
4. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299, 1995
5. el-Deiry WS, Haper JW, O'Connor PM, Velculescu VE, Camman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wimann KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzer KW, Vorgelstein B: WAF1/CIP1 is induced in p53: mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174, 1994
6. Waldman T, Kinzler KW, Vogelstein B: p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55: 5187-5190, 1995
7. Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578, 1994
8. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54: 3391-3395, 1994
9. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, OwenSchaub LB, Roth JA: Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 54: 2287-2291, 1994
10. Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH, Smith HS: Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84: 845-855, 1992
11. Iggo R, Gatter K, Bartek J, Lane D, Harris AL: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335: 675-679, 1990
12. Wang LD, Hong JY, Qiu SL, Gao H, Yang CS: Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomaker for carcinogenesis. Cancer Res 53: 1783-1787, 1993
13. Gao H, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS: p53 tumor supressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk population in Henan, China. Cancer Res 54: 4342-4346, 1994
14. Shin DM, Kim J, Ro JY, Hittelman J, Roth JA, Hong WK, Hittelman WN: Activation of p53 gene expression in premalignant lesions during head and neck tumorgenesis. Cancer Res 54: 321-326, 1994
15. Wang DY, Xiang YY, Tanaka M, Li XR, Li JL, Shen Q, Sugimura H, Kino I: High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Cancer 74: 3089-3096, 1994
16. Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lane DP, Hall PA: The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res 54: 614-617, 1994
17. Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993
18. Lowe SW, Bodies S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T: p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810, 1994
19. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992
20. Shin RW, Iwaki T, Kitamoto T, Tateishi J: Hydrate autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzherimer's disease brain tissues. Lab Invest 64: 693-702, 1991
21. Sasano H, Goukon Y, Nishihira T, Nagura H: In situ hybridization and immunohistochemistry of p53 tumor suppressor gene in human esophageal carcinoma. Am J Pathol 141: 545-550, 1992
22. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 55: 2910-2919, 1995
23. Barnes DM, Dublin EA, Fisher CJ, Levison DA, Millis RR: Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis? Hum Pathol 24: 469-476, 1993
24. Ito K, Watanabe K, Nasim S, Sasano H, Sato S, Yajima A, Silverberg SG, Garrett CT: Prognostic significance of p53 overexpression in endometrial cancer. Cancer Res 54: 4667-4670, 1994
25. Bardeesy N, Beckwith JB, Pelletier J: Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations. Cancer Res 55: 215-219, 1995
26. Meyn RE, Stephens LC, Ang KK, Hunter NR, Brock WA, Milas L, Peters LJ: Heterogeneity in the development of apoptosis in irradiated murine tumors of different histologies. Int J Radiat Biol 64: 583-591, 1993
27. Kellokumpu-Lehtinen P: Ultrastructual effects of therapeutic irradiation on human epithelial tumor. Scanning Microsc 6: 1035-1040, 1992
28. Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travail S, Deisseroth AB, Mercer WE: p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 55: 668-674, 1995
29. Soddu S, Blandino G, Citro G, Scardigli R, Piaggio G, Ferber A, Calabretta B, Sacchi A: Wild-type p53 gene expression induces granulocyte differentiation of HL-60 cells. Blood 83: 2230-2237, 1994
30. Rusch V, Klimstra D, Venkatraman E, Oliver J, Martini N, Gralla R, Kris M, Dmitrovsky E: Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer. Cancer Res 55: 5038-5042, 1995